The presence of normal concentrations of endogenous erythropoietin in all groups suggests a dysregulation Background. Recent experimental studies have found that erythropoietin elicits vasoconstriction and prolif-of erythropoietin in patients with essential hypertension as the pathophysiological link between erythropoeration of endothelial cells. We conducted the following study to assess the possible interactions between endo-ietin and vascular changes. genous erythropoietin, systemic and renal haemo-
I-II (age 52±10 years), and compared them to 42 Introduction normotensive individuals (age 26±3 years). The concentration of erythropoietin (radioimmunoassay), 24-h Progressively increased total peripheral resistance is a ambulatory blood pressure (Spacelab 90207), systemic characteristic haemodynamic feature in the develophaemodynamics ( Doppler sonography) and renal ment of essential hypertension even in the early stage haemodynamics (para-aminohippuric acid and inulin of essential hypertension [1 ] . Human recombinant clearance) were determined.
erythropoietin ( Epo), administered for the correction Results. Erythropoietin was within normal range and of anaemia in patients with end-stage renal disease, similar among the three groups. In patients with estabelevates arterial blood pressure in 25-30% of patients lished essential hypertension, a close correlation was on maintenance haemodialysis [2,3] which seems to be found between erythropoietin and systolic (r=0.45, due to a parallel increase of total peripheral resistance P<0.002) and diastolic (r=0.51, P<0.001) ambulat- [4, 5] . The elevation of the haematocrit, however, with ory blood pressure. In contrast, ambulatory blood the subsequent reduction of luxury perfusion in the pressure was not correlated with erythropoietin in periphery, does not or, if at all, only in part, account subjects with borderline hypertension. Total peripheral for the increase of total peripheral resistance after resistance (r=0.41, P<0.02) was linked to erythropotreatment with Epo [6, 7] . ietin in established but not in borderline hypertension.
A possible explanation for the blood pressure However, erythropoietin was inversely correlated with increase by Epo may be the fact that erythropoietin renal plasma flow in both established and borderline has been described to have vasoconstricting properties hypertension (r=−0.33, P<0.05, and r=−0.34, on isolated renal resistance vessels [8] . Moreover, P<0.05 respectively). In normotensive subjects, in endothelial cells have erythropoietin receptors and contrast, erythropoietin was not correlated with any respond with proliferation to Epo stimulation [9 ] . of the determined variables. In neither group erythroThese non-haemodynamic eÂects may lead to elevated poietin was linked to the haematocrit or hemoglobin vascular resistance and increased blood pressure. concentration.
Of note, patients on maintenance haemodialysis with Conclusion. The correlation between erythropoietin a positive family history of arterial hypertension are and renal vascular changes which is already present in at higher risk to respond with an increase of blood borderline hypertension and is confirmed in established pressure to Epo treatment [10 ] . Therefore, genetic hypertension indicates an involvement of erythropredisposition to hypertension is an important factor poietin in the development of essential hypertension.
not only for essential hypertension, but also for the development of arterial hypertension secondary to Epo
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Schmieder, Medizinische Klinik IV/Nephrologie, Universität sure in the past. Fifteen of 47 patients had a smoking history essential hypertension. In a cross-sectional study we with nine ex-smokers and six active smokers.
investigated the relation between endogenous Epo, Normotensive controls (NT, n=42, age 26±3 years) had blood pressure and systemic haemodynamics as well all casual blood pressure readings of ∏140/90 mmHg accordas renal haemodynamics in normotension, early ing to the protocol described above. All normotensive indiessential hypertension, and established essential vidual were healthy with no abnormal clinical or chemistry hypertension.
findings following the same protocol as hypertensive patients. No subject of this group had a family history of arterial hypertension. Seven of 42 persons were ex-smokers, and six were active smokers.
Subjects and methods

Study population Measurements
The following investigations were carried out in all participThree groups were recruited: first, patients with established essential hypertension ( EH ), second subjects with borderline ants. Non-invasive ambulatory BP monitoring was conducted with an automatic portable device (Spacelab 90207, essential hypertension ( BH ), and third normotensive subjects as controls ( NT ).
Redmond, USA). Measurement intervals were every 15 min during daytime (defined from 06:00 to 22:00) and every Patients with established essential hypertension ( EH, n= 49 ) had been referred to our University Hypertension Clinic 30 min during night-time. The 24-h BP profiles were analysed according to an individualized approach [12] . for evaluation and treatment of elevated blood pressure. All of the participating patients (aged 52±10 years) were diaMeasurements of renal haemodynamics were carried out in a semirecumbent position in a quiet room under resting gnosed to have arterial hypertension according to WHO criteria, i.e. the average of four casual blood pressure (BP) conditions at the same time of the day. We applied the constant infusion input technique ( Perfusor secura, Braun readings on two diÂerent occasions (at least 2 weeks apart) was Á160/95 mmHg. Casual BP was taken from the sitting Melsungen AG, Germany) to determine renal perfusion (para-aminohippuric acid-[PAH ] clearance) and glomerular patient after 5 min of rest with a standard sphygmomanometer. CuÂ size was adjusted according to the patient's arm filtration rate (inulin-clearance) as suggested by Cole and coworkers [13] , and previously described and revalidated in circumference. All patients either had never received any cardiovascular medication or the treatment had been discon-detail [14] . Blood samples for the determination of inulin and PAH were collected twice at minutes 105 and 120 and tinued at least 4 weeks before the study began and casual BP measurements were taken. None of the patients had were measured in duplicate for each sample. CoeÃcient of variation was less than 5% [14 ] . Filtration fraction was previously received angiotensin II antagonists or ACE inhibitors known to interact with erythropoietin [11 ] .
calculated by dividing glomerular filtration rate by renal plasma flow. Renal blood flow was estimated by dividing Each participating patient underwent a complete routine clinical workup including a complete medical history, phys-renal plasma flow by 1 minus the haematocrit. Renal vascular resistance was calculated as mean arterial BP divided by ical examination, urine analysis (dipstick and microscopic evaluation), and blood tests (serum concentration of urea, renal blood flow. Renal haemodynamic data were indexed to body surface area to allow comparison between groups creatinine, sodium, and potassium) to exclude WHO stage III of hypertensive disease and secondary hypertension. In par-with various body constitution.
Systemic haemodynamics were assessed non-invasively by ticular, 12-lead electrocardiogram at rest and with exercise, fundoscopy, and sonography of the kidneys were performed. continuous wave Doppler sonography (Picker-Hitachi CS 192, Tokyo, Japan, 2.5 MHz probe). The echocardiographic If indicated, intra-arterial digital substraction arteriography and endocrine investigations were carried out to exclude recordings were obtained at rest with the probe in the third or fourth intercostal space lateral to the left sternal border secondary causes of hypertension. Further exclusion criteria were advanced hypertensive fundoscopic changes, myocardial and the patient recumbent in the half left-sided position [ 15] .
All echocardiographic tracings were read independently by infarction or other evidence of coronary artery disease, congestive heart failure (New York Heart Association classes two physicians and in accordance with the American Society of Echocardiography (ASE) convention [16 ] . To assess II to IV ), and previous cerebrovascular event. All patients had a normal renal function ( by inulin clearance) and were stroke volume, continuous pulsed-wave doppler sonography was subsequently used. Stroke volume was calculated as the free of any renal disease according to clinical investigation. Forty-two of 49 patients were life-time non-smokers, 7 had product of cross-sectional area of the aortic valve ( long axis parasternal M-mode view) and the velocity time integral of a history of smoking (1 active smoker and 6 ex-smokers). All patients had no history or clinical signs of pulmonary left ventricular outflow obtained from the five-chamber view [17] . Cardiac output was calculated as stroke volume multidisease, in particular no patient had a history of chronic obstructive airway disease.
plied by heart rate, and total peripheral resistance was calculated as mean blood pressure divided by cardiac output. Subjects with borderline essential hypertension (BH, n= 47, age 26±3 years) were recruited from the Campus of the Blood samples were always collected at the same time in the morning in each patient for the determination of erythroUniversity Erlangen-Nuremberg at the occasion of screening for high blood pressure. Borderline hypertension was defined cyte count, haemoglobin, haematocrit, and endogenous Epo after the patients had rested for 1 h in the supine position. as casual BPÁ140 mmHg systolic or Á90 mmHg diastolic. Blood pressure measurements were taken according to the The blood samples for the determination of endogenous Epo were centrifuged at room temperature (18°C ) immediately protocol described above. Secondary hypertension, WHO stage III of hypertensive disease and other cardiovascular or after being taken from the patients, and plasma was rapidly frozen and stored at −20°C. Endogenous Epo was measured pulmonary disorders were excluded according to the protocol for established essential hypertension, as outlined above. No within 3 months with a commercially available radioimmunoassay kit ( EPO-Trac RIA Kit (23200), Sorin Bio Medica subject had received medical treatment for high blood pres-AG, Germany). CoeÃcient of variation was less than 6%. The mean endogenous Epo concentration was 15.0±3.6 mU/ml in the group with established hypertension, 16.0±7.6 mU/ml in the group with borderline hypertension, and 13.5±5.3 mU/ml in normotensive controls. The concentrations of endogenous Epo were within normal limits in all examined subjects [ 18] .
All statistical analysis was carried out using the SSPS-PC program [19] . ANOVA and ANCOVA testing was applied to compare the groups followed by the ScheÂe test for comparison between groups. Pearson correlation coeÃcients and multiple regression analysis was done when indicated. A value of P<0.05 (two-sided significance) was considered to be statistically significant. All values are given as mean±standard deviation. 
Clinical data
ing average daytime and night-time blood pressure Twenty-four-hour ambulatory blood pressure diÂered separately, Epo still correlated with the respective between groups (P<0.001, see Table 1 ). Casual BP in values (data not given). In a stepwise multiple regres-EH was 165±21/106±12 mmHg, in BH 145±11/-sion analysis, Epo was the strongest determinant of diastolic 24-h blood pressure (R2=0.30, b=0.49, P= 90±11 mmHg, and in NT 121±11/75±9 mmHg, 0.0009) compared to age ( b=0.19, n.s.) and body mass which was diÂerent by study design (P<0.001). Body index (b=−0.06, n.s. correlation with Epo in this group. mU/ml ) was equal to the one in BH (16.0±
In BH, as opposed to EH, neither 24-h systolic nor 7.6 mU/ml ) and NT ( 13.5±5.3 mU/ml ). In neither of diastolic blood pressure correlated with Epo concentrathe groups nor in the total study group Epo concentration. Similarly, no correlation was found between Epo tion correlated with hematocrit, haemoglobin concen-an 24-h systolic or diastolic blood pressure in NT. tration, or erythrocyte count.
Hence, a strong correlation between 24-h blood pressure and Epo was found in established essential Blood pressure hypertension, but not at the early stage of hypertension nor in the normotensive healthy state. In EH, a strong correlation was found between Epo concentration and 24-h blood pressure. The higher the Systemic haemodynamics concentration of Epo, the higher was 24-h systolic (r= 0.45, P<0.002, see Figure 1 ) and diastolic (r=0.51, The concentration of Epo was correlated with total peripheral resistance in EH. The higher Epo concentra-P<0.001) blood pressure in this group. When analys- tions, the higher was total peripheral resistance determined by dopplersonography (r=0.41, P<0.02, see Figure 2 ). Epo concentration did not show a correlation with cardiac output (r=−0.10, n.s.). In BH, no correlation was found between Epo and total peripheral resistance (r=0.08, n.s.) or cardiac output (r= −0.01, n.s.). Similarly, Epo was neither correlated with total peripheral resistance (r=−0.16, n.s.) nor cardiac output (r=0.26, n.s.) in NT. Thus, Epo correlated with total peripheral resistance in EH only.
Renal haemodynamics
Renal plasma flow was inversely correlated with Epo concentration in EH. The higher Epo, the lower was renal plasma flow in patients with essential hypertension (EH; r=−0.33, P<0.05, see Figure 3a ). Renal blood flow was linked to high Epo concentration (r= −0.35, P<0.05) as was renal vascular resistance (r= 0.38, P<0.02). Glomerular filtration rate only tended to be correlated with Epo (r=−0.30, P=0.052), and filtration fraction was not correlated with Epo (r= 0.12, n.s.).
In patients with borderline hypertension (BH ), high Epo concentrations were inversely related to renal plasma flow (r=−0.34, P<0.05, see Figure 3b ), renal blood flow (r=−0.34, P<0.05), and glomerular filtration rate (r=−0.58, P<0.001) but in a direct manner to renal vascular resistance (r=0.50, P<0.001). This contrasts the findings in the systemic Thus, endogenous Epo concentration was linked to As the most interesting result, the concentration of high renal vascular resistance and low renal plasma endogenous Epo was strongly correlated with elevated flow in EH in a similar way as in BH as opposed to 24-h blood pressure in patients with established essennormotensive controls where no such correlations tial hypertension. Total peripheral resistance was idenwere found.
tified as the underlying mechanism to which Epo was correlated in patients with established essential hypertension. Consistently, in patients on maintenance haemodialysis there is clear evidence that Epo administration increases total peripheral resistance independently from the rise in haematocrit, thereby causing an increase of arterial blood pressure [4, 5] . Also, intravenous Epo infusion lead to reduced muscle blood flow and increased vascular resistance in healthy normotensive individuals [20 ] . The concentration of endogenous Epo was within the limits of normal in all groups in the present study [18] and is in accordance with values found in essential hypertension in prior studies [21] [22] [23] . The correlation between vascular changes and endogenous Epo therefore cannot be explained by elevated levels of Epo.
Furthermore, we found a strong correlation between hyperbaric oxygenation is found in essential hyperten- 
